Skip to main content
. 2020 Oct 31;4(12):1793–1801. doi: 10.1002/hep4.1603

Table 1.

Descriptive Statistics of the Analytic Data Set by Sex

Categorical
Female Male
Count Percentage § Count Percentage §
Age (years)
<40 90 18.3 52 20.4
40‐64 310 56.8 141 51.2
65+ 119 24.9 61 28.5
Born in Mexico
No 141 33.5 103 41.2
Yes 377 66.5 152 58.8
Health Insurance*
No 280 50.1 123 41.0
Yes 237 49.9 131 59.0
BMI (kg/m2)
<20 4 0.6 0 0
20 to <25 83 16.3 28 8.1
25 to <30 164 33.0 100 38.5
30 to <35 229 42.3 110 45.1
≥35 38 7.8 16 8.5
Diabetes
No 370 74.6 173 72.0
Yes 142 25.4 79 28.0
Heavy drinking
No 516 99.8 243 96.2
Yes 3 0.2 12 3.8
HCV‐Ab positive 7 1.0 4 1.3
HBsAg positive 8 2.0 4 11.7
Continuous Variables
Female Male
Median § 95 CI § Median § 95 CI §
Age (continuous) 55 52, 57 53 50, 58
BMI (kg/m2) 30.0 29.2, 30.9 30.4 29.6, 31.6
Liver fibrosis (kPa) 4.5 4.3, 4.7 4.8 4.4, 5.3
APRI 0.2 0.22, 0.24 0.36 0.24, 0.28
NAFLD fibrosis score −1.8 −1.9, −1.7 −1.5 −1.7, −1.2
CAP (dB/m) 277 270, 288 306 278, 319
Fasting glucose (mg/dL) 93 92, 94 100 96, 104
HbA1c (%) 5.8 5.7, 5.9 5.9 5.8, 6.0
Fasting insulin (pmol/L) 9.3 8.7, 10.8 10.5 6.9, 13.7
HOMA‐IR || 2.4 2.1, 2.8 2.8 2.1, 3.8
Waist circumference (cm) 100 98, 102 105 102, 107
Platelet count (×103/uL) 253.8 248, 265 231.5 215, 244
AST (U/L) 19 18, 20 21 19, 23
ALT (U/L) 25 24, 27 32 28, 37.9
Triglycerides (mg/dL) 128 118, 138 141.5 124.7, 157.5
Total cholesterol (mg/dL) 187 182, 192 175.8 168, 186
HDL (mg/dL) 51 49, 53 41 38, 46
LDL (mg/dL) 107 102, 109 104 96, 110.3
*

Any health insurance, including private and public (Medicare/Medicaid) coverage.

According to the American Diabetes Association 2010 guidelines.

Defined as >14 drinks/week for female participants and >21 drinks/week for male participants.

§

All statistics are calculated using design‐based analysis accounting for complex sampling design.

||

Homeostasis model of insulin resistance, calculated using the formula glucose (mmol/L)* insulin (mU/L)/22.5.

Abbreviations: APRI, AST‐to‐platelet ratio index; BMI, Body Mass Index; CAP, controlled attenuation parameter; HBsAg, Heptatis B Surface Antigen; HCV‐Ab, Hepatitis C Virus Antibody; HDL, high‐density lipoprotein; kPa, kilopascals; LDL, low‐density lipoprotein; NAFLD, non‐alcoholic fatty liver disease.